221 related articles for article (PubMed ID: 24561225)
1. Diversity of proton pumps in osteoclasts: V-ATPase with a3 and d2 isoforms is a major form in osteoclasts.
Matsumoto N; Daido S; Sun-Wada GH; Wada Y; Futai M; Nakanishi-Matsui M
Biochim Biophys Acta; 2014 Jun; 1837(6):744-9. PubMed ID: 24561225
[TBL] [Abstract][Full Text] [Related]
2. From lysosomes to the plasma membrane: localization of vacuolar-type H+ -ATPase with the a3 isoform during osteoclast differentiation.
Toyomura T; Murata Y; Yamamoto A; Oka T; Sun-Wada GH; Wada Y; Futai M
J Biol Chem; 2003 Jun; 278(24):22023-30. PubMed ID: 12672822
[TBL] [Abstract][Full Text] [Related]
3. Atp6v0d2 is an essential component of the osteoclast-specific proton pump that mediates extracellular acidification in bone resorption.
Wu H; Xu G; Li YP
J Bone Miner Res; 2009 May; 24(5):871-85. PubMed ID: 19113919
[TBL] [Abstract][Full Text] [Related]
4. Luteolin inhibition of V-ATPase a3-d2 interaction decreases osteoclast resorptive activity.
Crasto GJ; Kartner N; Yao Y; Li K; Bullock L; Datti A; Manolson MF
J Cell Biochem; 2013 Apr; 114(4):929-41. PubMed ID: 23129004
[TBL] [Abstract][Full Text] [Related]
5. Functional complementation of V-ATPase a subunit isoforms in osteoclasts.
Matsumoto N; Sekiya M; Fujimoto Y; Haga S; Sun-Wada GH; Wada Y; Nakanishi-Matsui M
J Biochem; 2021 Apr; 169(4):459-466. PubMed ID: 33135054
[TBL] [Abstract][Full Text] [Related]
6. A rationale for osteoclast selectivity of inhibiting the lysosomal V-ATPase a3 isoform.
Nyman JK; Väänänen HK
Calcif Tissue Int; 2010 Sep; 87(3):273-83. PubMed ID: 20596699
[TBL] [Abstract][Full Text] [Related]
7. The a3 isoform of the 100-kDa V-ATPase subunit is highly but differentially expressed in large (>or=10 nuclei) and small (Manolson MF; Yu H; Chen W; Yao Y; Li K; Lees RL; Heersche JN
J Biol Chem; 2003 Dec; 278(49):49271-8. PubMed ID: 14504271
[TBL] [Abstract][Full Text] [Related]
8. Vacuolar H+-ATPase d2 subunit: molecular characterization, developmental regulation, and localization to specialized proton pumps in kidney and bone.
Smith AN; Jouret F; Bord S; Borthwick KJ; Al-Lamki RS; Wagner CA; Ireland DC; Cormier-Daire V; Frattini A; Villa A; Kornak U; Devuyst O; Karet FE
J Am Soc Nephrol; 2005 May; 16(5):1245-56. PubMed ID: 15800125
[TBL] [Abstract][Full Text] [Related]
9. V-ATPase a3 isoform mutations identified in osteopetrosis patients abolish its expression and disrupt osteoclast function.
Matsumoto N; Matsukawa R; Takahashi S; Kudo K; Sun-Wada GH; Wada Y; Nakanishi-Matsui M
Exp Cell Res; 2020 Apr; 389(2):111901. PubMed ID: 32045577
[TBL] [Abstract][Full Text] [Related]
10. Structure and function of V-ATPases in osteoclasts: potential therapeutic targets for the treatment of osteolysis.
Xu J; Cheng T; Feng HT; Pavlos NJ; Zheng MH
Histol Histopathol; 2007 Apr; 22(4):443-54. PubMed ID: 17290355
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the osteoclast V-ATPase by small interfering RNAs.
Hu Y; Nyman J; Muhonen P; Väänänen HK; Laitala-Leinonen T
FEBS Lett; 2005 Sep; 579(22):4937-42. PubMed ID: 16115623
[TBL] [Abstract][Full Text] [Related]
12. Atp6v1c1 is an essential component of the osteoclast proton pump and in F-actin ring formation in osteoclasts.
Feng S; Deng L; Chen W; Shao J; Xu G; Li YP
Biochem J; 2009 Jan; 417(1):195-203. PubMed ID: 18657050
[TBL] [Abstract][Full Text] [Related]
13. Murine ameloblasts are immunonegative for Tcirg1, the v-H-ATPase subunit essential for the osteoclast plasma proton pump.
Bronckers AL; Lyaruu DM; Bervoets TJ; Medina JF; DenBesten P; Richter J; Everts V
Bone; 2012 Apr; 50(4):901-8. PubMed ID: 22245629
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of osteoclast bone resorption by disrupting vacuolar H+-ATPase a3-B2 subunit interaction.
Kartner N; Yao Y; Li K; Crasto GJ; Datti A; Manolson MF
J Biol Chem; 2010 Nov; 285(48):37476-90. PubMed ID: 20837476
[TBL] [Abstract][Full Text] [Related]
15. Three subunit a isoforms of mouse vacuolar H(+)-ATPase. Preferential expression of the a3 isoform during osteoclast differentiation.
Toyomura T; Oka T; Yamaguchi C; Wada Y; Futai M
J Biol Chem; 2000 Mar; 275(12):8760-5. PubMed ID: 10722719
[TBL] [Abstract][Full Text] [Related]
16. The osteoclast proton pump differs in its pharmacology and catalytic subunits from other vacuolar H(+)-ATPases.
Chatterjee D; Chakraborty M; Leit M; Neff L; Jamsa-Kellokumpu S; Fuchs R; Bartkiewicz M; Hernando N; Baron R
J Exp Biol; 1992 Nov; 172():193-204. PubMed ID: 1491225
[TBL] [Abstract][Full Text] [Related]
17. Osteoclasts express the B2 isoform of vacuolar H(+)-ATPase intracellularly and on their plasma membranes.
Lee BS; Holliday LS; Ojikutu B; Krits I; Gluck SL
Am J Physiol; 1996 Jan; 270(1 Pt 1):C382-8. PubMed ID: 8772466
[TBL] [Abstract][Full Text] [Related]
18. Bovine parathyroid hormone enhances osteoclast bone resorption by modulating V-ATPase through PTH1R.
Liu S; Zhu W; Li S; Ma J; Zhang H; Li Z; Zhang L; Zhang B; Li Z; Liang X; Shi W
Int J Mol Med; 2016 Feb; 37(2):284-92. PubMed ID: 26647715
[TBL] [Abstract][Full Text] [Related]
19. Defective assembly of a hybrid vacuolar H(+)-ATPase containing the mouse testis-specific E1 isoform and yeast subunits.
Hayashi K; Sun-Wada GH; Wada Y; Nakanishi-Matsui M; Futai M
Biochim Biophys Acta; 2008 Oct; 1777(10):1370-7. PubMed ID: 18662668
[TBL] [Abstract][Full Text] [Related]
20. v-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation.
Lee SH; Rho J; Jeong D; Sul JY; Kim T; Kim N; Kang JS; Miyamoto T; Suda T; Lee SK; Pignolo RJ; Koczon-Jaremko B; Lorenzo J; Choi Y
Nat Med; 2006 Dec; 12(12):1403-9. PubMed ID: 17128270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
